Fig. 3From: Triple negative breast cancer and platinum-based systemic treatment: a meta-analysis and systematic reviewForest plot showing pooled incidence of pCR in subgroup of TNBC patients given Carboplatin/Paclitaxel (Top), and Platinum/Anthracycline (Bottom)Back to article page